Carcinoma, Bronchogenic: all 66 studies

Page 1 of 1. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.

• EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid TumorsRecruitingNCT07410676Phase 1/2
• Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.RecruitingNCT07279935Phase 4
• Development of Clinical and Biological Database on Bronchial CancerRecruitingNCT07085429Not applicable
• Evaluation of Skin Tests in Biotherapy AllergiesRecruitingNCT06971848Not applicable
• Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLCRecruitingNCT06623656Phase 2
• A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLCRecruitingNCT06177925Phase 2
• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerRecruitingNCT06119581Phase 3
• Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerRecruitingNCT05297734Not applicable
• Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During RadiotherapyRecruitingNCT04517019Not applicable
• LUng CAncer focuS - Long-term Monitoring of Bronchogenic Carcinoma Patients (LUCAS)RecruitingNCT04228237
• A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 RearrangementsRecruitingNCT03093116Phase 1/2
• Veterans Affairs Lung Cancer Surgery Or Stereotactic RadiotherapyRecruitingNCT02984761Not applicable
• Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)CompletedNCT04776447Phase 2Results posted
• A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid TumorsTerminatedNCT04644315Phase 2Results posted
• Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated PatientsTerminatedNCT04512430Phase 2Results posted
• A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT04222972Phase 3Results posted
• A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) TumorsActive, not recruitingNCT03899792Phase 1/2Results posted
• A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)Active, not recruitingNCT03157128Phase 1/2Results posted
• Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsCompletedNCT03037385Phase 1/2Results posted
• Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung CancerCompletedNCT02904954Phase 2Results posted
• Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)CompletedNCT01999985Phase 1Results posted
• Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)Active, not recruitingNCT07162883Phase 3
• Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLCNo longer availableNCT06841874
• A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA)Active, not recruitingNCT06606847Phase 2
• Efficacy and Safety Study of DURVALUMAB Maintenance in Patients With Stage III Non-Small Cell Lung CancerActive, not recruitingNCT06564870
• Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) StudyActive, not recruitingNCT06494241
• Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLCActive, not recruitingNCT06376084
• A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based ChemotherapyActive, not recruitingNCT05941897Phase 2
• A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid TumorsStatus unknownNCT05886075Early Phase 1
• Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0)CompletedNCT05605236
• (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion MutationsTerminatedNCT05241873Phase 1
• (HARMONY) Study of BLU-701 in EGFR-mutant NSCLCTerminatedNCT05153408Phase 1
• CAncer, NUtrition and Taste 2CompletedNCT05027490Not applicable
• (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLCTerminatedNCT04862780Phase 1
• Feasibility of Immunotherapy Plus Chemotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home SettingCompletedNCT04802902
• Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid TumorsCompletedNCT04774952Phase 1
• External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLCStatus unknownNCT04697446
• New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapyActive, not recruitingNCT04564157Phase 3
• Effectiveness of Care in Certified Cancer Centres in GermanyCompletedNCT04334239
• Feasibility of Immunotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home Setting (ImHADom)CompletedNCT03786653
• Rehabilitation by Effort for Patients With Advanced Bronchial CancerTerminatedNCT03684486Not applicable
• Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid TumorsStatus unknownNCT03634982Phase 1
• The EPIC Trial The Elderly Patient Individualized Chemotherapy TrialStatus unknownNCT03402048Phase 3
• CT Scan Guide Percutaneous Biopsy of Lytic Bone Metastases of Lung Cancer : Contribution in Pathology Diagnosis and Molecular BiologyStatus unknownNCT03386916
• Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung CancerCompletedNCT03331588Phase 3
• Kinetics of Circulating Tumoral Cells in Bronchial Primitive CancerCompletedNCT03328559Not applicable
• A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLCCompletedNCT03134872Phase 3
• A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLCStatus unknownNCT03085069Phase 2
• A Phase III Trial of Recombinant Human Apo-2 Ligand for InjectionStatus unknownNCT03083743Phase 3
• Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)TerminatedNCT03053297
• Study of the Quality of Lung ResectionStatus unknownNCT02877043
• Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC PatientsStatus unknownNCT02804100
• Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung CancerStatus unknownNCT02648087Not applicable
• Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer DiagnosticsStatus unknownNCT02441972Phase 1
• Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung CancerStatus unknownNCT02288026
• SAS in Patients With Bronchial CarcinomaStatus unknownNCT02270853Not applicable
• Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung CancerCompletedNCT01594398Phase 1
• A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung CancerTerminatedNCT01574222Phase 1
• Tumour Registry Lung Cancer (TLK)CompletedNCT01192919
• Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung CancerCompletedNCT01058785Phase 2
• A New Pathway With BronchOscopic or Oesophageal Ultrasound for Lung Cancer Diagnosis and STaging (BOOST)CompletedNCT00652769Phase 3
• Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsCompletedNCT00413322Phase 1
• Randomized Trial of Fluticasone in Bronchial PremalignancyCompletedNCT00407264Phase 2
• Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise TrainingCompletedNCT00196885Phase 2
• A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00102505Phase 1
• Diagnostic Effectiveness of Virtual BronchoscopyCompletedNCT00001515Phase 1

← Carcinoma, Bronchogenic overview